MX9306467A - Formulacion novedosa. - Google Patents

Formulacion novedosa.

Info

Publication number
MX9306467A
MX9306467A MX9306467A MX9306467A MX9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A MX 9306467 A MX9306467 A MX 9306467A
Authority
MX
Mexico
Prior art keywords
novel formulation
vacuum atmosphere
solution
atmosphere
polyoxypropylene
Prior art date
Application number
MX9306467A
Other languages
English (en)
Spanish (es)
Inventor
Mary Sou
Craig William Davis
Alison Green Floyd
Original Assignee
Wellcome Foudation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foudation Limited filed Critical Wellcome Foudation Limited
Publication of MX9306467A publication Critical patent/MX9306467A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
MX9306467A 1992-10-19 1993-10-18 Formulacion novedosa. MX9306467A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation

Publications (1)

Publication Number Publication Date
MX9306467A true MX9306467A (es) 1994-05-31

Family

ID=10723654

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306467A MX9306467A (es) 1992-10-19 1993-10-18 Formulacion novedosa.

Country Status (19)

Country Link
EP (1) EP0671919A1 (en:Method)
JP (1) JPH08502284A (en:Method)
KR (1) KR950703345A (en:Method)
AU (1) AU674895B2 (en:Method)
BR (1) BR9307268A (en:Method)
CA (1) CA2147889A1 (en:Method)
CZ (1) CZ63395A3 (en:Method)
GB (1) GB9221883D0 (en:Method)
HU (1) HUT75701A (en:Method)
IL (1) IL107313A0 (en:Method)
MX (1) MX9306467A (en:Method)
NO (1) NO951462L (en:Method)
NZ (1) NZ256890A (en:Method)
PL (1) PL308459A1 (en:Method)
SI (1) SI9300545A (en:Method)
SK (1) SK44795A3 (en:Method)
TW (1) TW276183B (en:Method)
WO (1) WO1994008596A1 (en:Method)
ZA (1) ZA937714B (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008287419A1 (en) * 2007-08-10 2009-02-19 Synthrx, Inc. Polymer therapy for the treatment of chronic microvascular diseases
WO2015058013A1 (en) 2013-10-16 2015-04-23 Mast Therapeutics, Inc. Diuretic induced alterations of plasma volume
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
KR102525493B1 (ko) 2014-07-07 2023-04-25 라이프래프트 바이오사이언시즈 인코포레이티드 장기 순환 물질이 없는 폴록사머 조성물 및 이의 제조 방법 및 용도
CN109432511A (zh) * 2018-12-29 2019-03-08 常州乐奥医疗科技股份有限公司 一种温敏型水凝胶及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia

Also Published As

Publication number Publication date
TW276183B (en:Method) 1996-05-21
NO951462L (no) 1995-06-13
AU5284293A (en) 1994-05-09
SI9300545A (en) 1994-06-30
IL107313A0 (en) 1994-01-25
CA2147889A1 (en) 1994-04-28
SK44795A3 (en) 1996-05-08
HU9501104D0 (en) 1995-06-28
AU674895B2 (en) 1997-01-16
WO1994008596A1 (en) 1994-04-28
ZA937714B (en) 1995-04-18
JPH08502284A (ja) 1996-03-12
KR950703345A (ko) 1995-09-20
PL308459A1 (en) 1995-07-24
CZ63395A3 (en) 1995-07-12
NO951462D0 (no) 1995-04-18
BR9307268A (pt) 1999-05-11
EP0671919A1 (en) 1995-09-20
NZ256890A (en) 1995-10-26
GB9221883D0 (en) 1992-12-02
HUT75701A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
AU554402B2 (en) Double sterile package
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
ES2098029T3 (es) Vacunas de hepatitis que contienen monofosforil lipido a 3-o-desacilado.
DE59310197D1 (de) Lagerstabile wässrige pharmazeutische zubereitungen von g-csf
MX9207374A (es) Preparacion farmaceutica que comprende una hormonade crecimiento o un derivado de la hormona de crecimiento e histidina o un derivado de histidina.
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
MX9710206A (es) Composicion farmaceutica de amiodarone para administracion parenteral.
DE3766200D1 (de) L-dopa enthaltendes arzneimittel.
AU3855297A (en) Pharmaceutical composition for treating papillomavirus tumours and infection
TW327602B (en) A pharmaceutical composition of an ophthalmic suspension containing difluprednate
AU2845295A (en) Peelable package with oxygen scavening layer
MX9306467A (es) Formulacion novedosa.
DK0517160T3 (da) Oftalmiske præparater med forlænget frigivelse
AU4445089A (en) Lactamimides in the treatment of drug-resistant protozoal infections
AU4434189A (en) An anti-human immunodeficiency virus composition
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
DE59409275D1 (de) Tabletten mit Thioctsäure bestimmter Korngrösse
AU674379B2 (en) Antitussive
IT1260469B (it) Macchina inscatolatrice per fiale in particolare del tipo in vetro ad uso medico
SG49770A1 (en) Pharmaceutical preparation
NZ333656A (en) Liquid formulation comprising less 5% w/w saturated polyglycosylated C8-10 glycerides (capryl caproyl macrogol glycerides) and a non-peptide for oro-mucosal administration
YU65493A (sh) Novi preparat blok kopolimera
NZ236888A (en) Antibiotic deoxymulundocandin, preparation from aspergillus sydowii culture
DE69112028D1 (de) Arzneizusammensetzungen zur rektalen Verabreichung enthaltend gefriergetrocknetes Calcitonin.
AU623386B2 (en) 1-dimethylcarbamoyl-3-substituted-5-substituted-1h-1,2,4- triazoles